Bahrain approves Sinopharms COVID vaccine for use
2020-12-14 09:18
PhotoAgencies    MANAMA  Bahrains health regulator on Sunday announced it has officially approved the registration of a COVID vaccine developed by the China National Pharmaceutical Group, or Sinopharm, according to Bahrain News Agency. The National Health Regulatory Authority made the decision to approve and use the vaccine after thorough review and evaluation of the clinical trials data, the report said. Results from Phase III clinical trials showed an  percent efficacy rate, a  percent seroconversion rate of neutralizing antibody and  percent effectiveness in preventing moderate and severe cases of COVID, following testing on , volunteers, said the report. Bahrain, which has participated in Phase III clinical trials of the vaccine in August, authorized the emergency use of Sinopharms vaccine in November to cover those frontline professionals in contact with COVID patients.